X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9405) 9405
Publication (499) 499
Newspaper Article (181) 181
Book Review (162) 162
Newsletter (141) 141
Magazine Article (130) 130
Book Chapter (50) 50
Trade Publication Article (20) 20
Book / eBook (13) 13
Conference Proceeding (11) 11
Web Resource (6) 6
Dissertation (5) 5
Reference (5) 5
Data Set (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8124) 8124
diuretics (4039) 4039
female (3928) 3928
male (3834) 3834
diuretics - adverse effects (3518) 3518
middle aged (3007) 3007
diuretics - therapeutic use (2962) 2962
aged (2841) 2841
hypertension - drug therapy (2545) 2545
index medicus (2111) 2111
adult (2025) 2025
hypertension (1765) 1765
drug therapy, combination (1197) 1197
antihypertensive agents - therapeutic use (1142) 1142
risk factors (1117) 1117
antihypertensive agents - adverse effects (1067) 1067
treatment outcome (965) 965
blood pressure - drug effects (939) 939
diuretics - administration & dosage (939) 939
medicine, general & internal (929) 929
heart failure - drug therapy (907) 907
heart failure (837) 837
mortality (827) 827
pharmacology & pharmacy (815) 815
cardiac & cardiovascular systems (744) 744
benzothiadiazines (737) 737
drug therapy (737) 737
aged, 80 and over (733) 733
blood pressure (728) 728
sodium chloride symporter inhibitors - adverse effects (710) 710
animals (664) 664
angiotensin-converting enzyme inhibitors - therapeutic use (654) 654
hypertension - physiopathology (592) 592
time factors (590) 590
adrenergic beta-antagonists - therapeutic use (580) 580
hypokalemia - chemically induced (556) 556
double-blind method (545) 545
diuretics - pharmacology (539) 539
risk (534) 534
sodium chloride symporter inhibitors - therapeutic use (519) 519
research (502) 502
care and treatment (490) 490
hypertension - complications (487) 487
peripheral vascular disease (475) 475
clinical trials as topic (458) 458
therapy (458) 458
patients (446) 446
furosemide - therapeutic use (445) 445
furosemide (444) 444
furosemide - adverse effects (444) 444
blood-pressure (443) 443
dose-response relationship, drug (442) 442
adolescent (436) 436
angiotensin-converting enzyme inhibitors - adverse effects (430) 430
retrospective studies (423) 423
health aspects (420) 420
prospective studies (420) 420
calcium channel blockers - therapeutic use (416) 416
hydrochlorothiazide (416) 416
potassium - blood (406) 406
hydrochlorothiazide - adverse effects (404) 404
adrenergic beta-antagonists - adverse effects (396) 396
drug interactions (391) 391
antihypertensive agents - administration & dosage (385) 385
hydrochlorothiazide - therapeutic use (384) 384
analysis (381) 381
diabetes (374) 374
management (361) 361
drugs (354) 354
follow-up studies (352) 352
potassium (351) 351
urology & nephrology (342) 342
antihypertensive drugs (339) 339
medicine & public health (337) 337
dosage and administration (334) 334
heart failure - physiopathology (322) 322
studies (312) 312
internal medicine (305) 305
age factors (298) 298
clinical trials (298) 298
furosemide - administration & dosage (291) 291
drug dosages (287) 287
prognosis (286) 286
medicine (283) 283
complications and side effects (281) 281
abridged index medicus (276) 276
prevention (276) 276
kidney - drug effects (272) 272
drug combinations (271) 271
angiotensin (264) 264
cardiology (263) 263
child (259) 259
cardiovascular disease (257) 257
randomized controlled trials as topic (255) 255
hyponatremia - chemically induced (254) 254
calcium channel blockers - adverse effects (252) 252
double-blind (251) 251
acute disease (250) 250
trial (250) 250
research article (244) 244
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8386) 8386
German (433) 433
French (299) 299
Japanese (172) 172
Italian (117) 117
Spanish (112) 112
Russian (97) 97
Danish (55) 55
Norwegian (53) 53
Polish (38) 38
Dutch (35) 35
Swedish (23) 23
Portuguese (18) 18
Hungarian (17) 17
Chinese (13) 13
Czech (13) 13
Bulgarian (11) 11
Hebrew (11) 11
Finnish (10) 10
Romanian (9) 9
Croatian (3) 3
Turkish (3) 3
Korean (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 07/2011, Volume 58, Issue 4, pp. 383 - 385
Journal Article
Journal Article
2013, Pharmacology-research, safety testing and regulation, ISBN 1628082569
Web Resource
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Clinical trials | Family medical history | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Fatal | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
Psychopraxis. Neuropraxis, ISSN 2197-9707, 09/2015, Volume 18, Issue 4, p. 141
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00739-015-0251-4 Ein... 
Complications and side effects | Psychiatric hospital care | Diuretics | Bipolar disorder | Poisoning | Psychiatric hospitals
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9721, pp. 1173 - 1181
Summary Background The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that... 
Internal Medicine | KIDNEY-DISEASE | AMLODIPINE | BENAZEPRIL | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME-INHIBITOR | ALBUMINURIA | NITRIC-OXIDE | INSUFFICIENCY | DIABETIC-NEPHROPATHY | BLOOD-PRESSURE | PROGRESSION | Blood Pressure | Calcium Channel Blockers - adverse effects | Benzazepines - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Kidney Failure, Chronic - urine | Male | Albuminuria | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Amlodipine - administration & dosage | Hydrochlorothiazide - adverse effects | Kidney Failure, Chronic - physiopathology | Diuretics - administration & dosage | Glomerular Filtration Rate | Double-Blind Method | Risk Factors | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Disease Progression | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Calcium Channel Blockers - administration & dosage | Kidney Failure, Chronic - complications | Creatinine - blood | Hypertension - complications | Aged | Benzazepines - administration & dosage | Diuretics - adverse effects | Drug Combinations | Hypertension | Chronic kidney failure | Patient outcomes | Development and progression | Drug therapy, Combination | Drug therapy | Methods | Risk factors | Studies | Heart failure | Blister packs | Mortality | Kidney diseases | Diabetes | Drugs | blood pressure | Side effects | Filtration | secondary analysis | Dialysis | clinical trials | hypertension | Kidney
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 18, pp. 1887 - 1898
Journal Article